CallidusCloud Announces Record Second Quarter Revenue of $61.3 Million
Aug 03, 2017 20:03 pm UTC| Business
Q2 SaaS Revenue Increases 32% to $47.7 MillionUpdates Full Year SaaS Revenue Guidance to $194.0 to $197.0 Million, 28 to 30% growth rateRaises Full Year Total Revenue Guidance to $245.0 to $248.0 MillionCash from...
Aerojet Rocketdyne Holdings, Inc. Reports Second Quarter 2017 Results
Aug 03, 2017 20:03 pm UTC| Business
EL SEGUNDO, Calif., Aug. 03, 2017 -- Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) today reported results for the second quarter ended June 30, 2017. Financial Overview Second quarter of fiscal 2017 compared with...
Entellus Medical Announces Second Quarter 2017 Financial Results
Aug 03, 2017 20:03 pm UTC| Business
PLYMOUTH, Minn., Aug. 03, 2017 -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive...
Aug 03, 2017 20:02 pm UTC| Business
LOS ANGELES, Aug. 03, 2017 -- Air Lease Corporation (NYSE:AL) (the “Company” or “ALC”) today announced that a wholly-owned subsidiary of the Company entered into a joint venture with a co-investment vehicle (the “JV...
Xenon Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 03, 2017 20:02 pm UTC| Business
BURNABY, British Columbia, Aug. 03, 2017 -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today reported its financial results for the quarter ended June 30, 2017, and provided a...
Stericycle, Inc. Reports Results for the Second Quarter and Year to Date 2017
Aug 03, 2017 20:02 pm UTC| Business
Lake Forest, Ill., Aug. 03, 2017 -- Stericycle, Inc. (NASDAQ:SRCL) today reported financial results for the second quarter and year to date 2017. SECOND QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: Revenues of $917.7...
Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
Aug 03, 2017 20:02 pm UTC| Business
MENLO PARK, Calif., Aug. 03, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal...